Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or major omissions.
301230SZSE
Announcement on the Change of Sponsoring Representative
✨ AI Summary
Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. announced the replacement of its sponsoring representative due to personal work adjustments of Mr. Wang Qi. Mr. Yuan Binlong has been appointed to continue the ongoing supervision work alongside Mr. Li Song. This change will not affect the company's operations or the ongoing supervision by CITIC Securities.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.